AG˹ٷ

STOCK TITAN

[Form 4] Omega Healthcare Investors Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Codexis, Inc. (CDXS) received a Form 4 filing from Opaleye Management Inc., a 10% beneficial owner, detailing an open-market purchase completed on 27 June 2025.

  • Transaction: 100,000 shares of Codexis common stock were purchased (Code P) at an average price of $2.39 per share.
  • Post-transaction holdings: Opaleye now reports 12,350,000 shares held indirectly through Opaleye, L.P. and an additional 250,000 shares in a separately managed account, bringing total reported beneficial ownership to 12.6 million shares.
  • Ownership form: All shares are reported as indirect (Form I); the investment manager disclaims beneficial ownership beyond its pecuniary interest.
  • Reporting party status: Opaleye is classified as a 10% owner; no board or executive role is indicated.

The filing signals incremental insider accumulation by a large shareholder. While the 100 k-share purchase is modest relative to the 12.35 million-share position, fresh buying can be interpreted by investors as a vote of confidence in Codexis at current price levels. No derivative transactions, sales or options were disclosed in this filing.

Codexis, Inc. (CDXS) ha ricevuto una comunicazione Form 4 da parte di Opaleye Management Inc., un azionista beneficiario del 10%, che dettaglia un acquisto sul mercato aperto completato il 27 giugno 2025.

  • Transazione: sono state acquistate 100.000 azioni ordinarie di Codexis (Codice P) a un prezzo medio di $2,39 per azione.
  • Detenzione post-transazione: Opaleye riporta ora un totale di 12.350.000 azioni detenute indirettamente tramite Opaleye, L.P. e ulteriori 250.000 azioni in un conto gestito separatamente, portando la proprietà beneficiaria totale segnalata a 12,6 milioni di azioni.
  • Forma di proprietà: Tutte le azioni sono riportate come indirette (Modulo I); il gestore degli investimenti nega la proprietà beneficiaria oltre il proprio interesse pecuniario.
  • Stato della parte segnalante: Opaleye è classificata come un azionista con oltre il 10% di partecipazione; non sono indicati ruoli nel consiglio o esecutivi.

La comunicazione indica un accumulo incrementale da parte di un grande azionista interno. Sebbene l’acquisto di 100.000 azioni sia modesto rispetto alla posizione di 12,35 milioni di azioni, l’acquisto può essere interpretato dagli investitori come un segnale di fiducia in Codexis ai livelli attuali di prezzo. Non sono state divulgate transazioni su derivati, vendite o opzioni in questa comunicazione.

Codexis, Inc. (CDXS) recibió una presentación Formulario 4 de Opaleye Management Inc., un propietario beneficiario del 10%, que detalla una compra en mercado abierto completada el 27 de junio de 2025.

  • հԲó: se adquirieron 100,000 acciones ordinarias de Codexis (Código P) a un precio promedio de $2.39 por acción.
  • Tenencia post-transacción: Opaleye reporta ahora 12,350,000 acciones mantenidas indirectamente a través de Opaleye, L.P. y otras 250,000 acciones en una cuenta gestionada por separado, sumando una propiedad beneficiaria total reportada de 12.6 millones de acciones.
  • Forma de propiedad: Todas las acciones se reportan como indirectas (Formulario I); el gestor de inversiones renuncia a la propiedad beneficiaria más allá de su interés pecuniario.
  • Estado de la parte reportante: Opaleye está clasificada como un propietario del 10%; no se indica ningún rol en la junta o ejecutivo.

La presentación señala una acumulación incremental por parte de un gran accionista interno. Aunque la compra de 100,000 acciones es modesta en relación con la posición de 12.35 millones de acciones, la compra fresca puede interpretarse por los inversores como un voto de confianza en Codexis a los niveles actuales de precio. No se divulgaron transacciones de derivados, ventas u opciones en esta presentación.

Codexis, Inc. (CDXS)� 10% 지� 보유자인 Opaleye Management Inc.로부� 2025� 6� 27�� 완료� 공개 시장 매수� 관� Form 4 신고� 받았습니�.

  • 거래 내용: Codexis 보통� 100,000주를 주당 평균 $2.39구매(코드 P)였습니�.
  • 거래 � 보유�: 貹� Opaleye, L.P.� 통해 간접적으� 12,350,000주와 별도� 관리되� 계좌� 250,000주를 보유하여 � 1,260� 주의 실질 소유권을 보고하고 있습니다.
  • 소유 형태: 모든 주식은 간접 소유(Form I)� 보고되었으며, 투자 매니저� 금전� 이익 이상� 실질 소유권을 부인합니다.
  • 보고� 지�: 貹� 10% 소유�� 분류되며, 이사회나 경영� 역할은 없습니다.

이번 신고� 대주주 내부자의 점진� 주식 매입� 나타냅니�. 100,000� 매수� 1,235� � 보유� 비해 적은 규모지�, 신규 매수� 투자자들에게 � 가� 수준에서 Codexis� 대� 신뢰� 표시� 해석� � 있습니다. 이번 신고에서� 파생상품 거래, 매도 또는 옵션 거래� 공개되지 않았습니�.

Codexis, Inc. (CDXS) a reçu un dépôt de Formulaire 4 de la part de Opaleye Management Inc., un détenteur bénéficiaire à 10%, détaillant un achat sur le marché ouvert réalisé le 27 juin 2025.

  • Transaction : 100 000 actions ordinaires de Codexis ont été achetées (Code P) à un prix moyen de 2,39 $ par action.
  • Position après transaction : Opaleye déclare désormais détenir indirectement 12 350 000 actions via Opaleye, L.P. et 250 000 actions supplémentaires dans un compte géré séparément, portant la propriété bénéficiaire totale déclarée à 12,6 millions ’aپDzԲ.
  • Forme de propriété : Toutes les actions sont déclarées comme indirectes (Formulaire I) ; le gestionnaire d’investissement décline toute propriété bénéficiaire au-delà de son intérêt pécuniaire.
  • Statut du déclarant : Opaleye est classé comme un détenteur de 10% ; aucun rôle au conseil d’administration ou exécutif n’est indiqué.

Le dépôt signale une accumulation progressive d’initiés par un grand actionnaire. Bien que l’achat de 100 000 actions soit modeste par rapport à la position de 12,35 millions d’actions, ce nouvel achat peut être interprété par les investisseurs comme un vote de confiance en Codexis aux niveaux de prix actuels. Aucune transaction sur dérivés, vente ou option n’a été divulguée dans ce dépôt.

Codexis, Inc. (CDXS) erhielt eine Form 4-Meldung von Opaleye Management Inc., einem 10%-Begünstigten, die einen am 27. Juni 2025 abgeschlossenen Kauf am offenen Markt beschreibt.

  • Transaktion: 100.000 Aktien der Codexis-Stammaktien wurden zu einem durchschnittlichen Preis von 2,39 $ pro Aktie gekauft (Code P).
  • Bestand nach der Transaktion: Opaleye meldet nun 12.350.000 Aktien, die indirekt über Opaleye, L.P. gehalten werden, sowie weitere 250.000 Aktien in einem separat verwalteten Konto, was eine insgesamt gemeldete wirtschaftliche Eigentümerschaft von 12,6 Millionen Aktien ergibt.
  • Form der Eigentümerschaft: Alle Aktien werden als indirekt (Formular I) gemeldet; der Investmentmanager lehnt eine wirtschaftliche Eigentümerschaft über sein pecuniäres Interesse hinaus ab.
  • Status der meldenden Partei: Opaleye wird als 10%-Գü eingestuft; keine Vorstands- oder Führungsfunktion wird angegeben.

Die Meldung signalisiert eine schrittweise Insider-Akkumulation durch einen Großaktionär. Obwohl der Kauf von 100.000 Aktien im Verhältnis zu der Position von 12,35 Millionen Aktien gering ist, kann der frische Kauf von Investoren als Vertrauensbeweis in Codexis zu den aktuellen Kursniveaus interpretiert werden. In dieser Meldung wurden keine Derivatgeschäfte, Verkäufe oder Optionen offengelegt.

Positive
  • 10% owner purchased 100,000 shares at $2.39, signalling confidence and raising total indirect stake to 12.35 million shares.
Negative
  • None.

Insights

TL;DR 10% owner Opaleye adds 100 k shares, lifting indirect stake to 12.35 m; modest but positive insider-buy signal.

Analysis: The $2.39 purchase price sits near recent lows, implying the investor views shares as undervalued. Although the incremental buy represents less than 1% of Opaleye’s existing position, continued accumulation by a fund already above the 10% threshold can bolster market sentiment. No sales or hedges were reported, reducing concerns of near-term distribution. Absent earnings data, the purchase is a standalone bullish indicator rather than confirmation of fundamental improvement.

TL;DR Additional indirect insider purchase strengthens alignment but retains disclaimer of true beneficial ownership.

The filing underscores sustained economic exposure by Opaleye without altering governance dynamics—no board seat, no direct control. Indirect holding structure limits transparency, yet repeated open-market buying typically aligns interests with minority shareholders. The absence of derivative grants or preferential terms suggests market-rate acquisition, lowering agency-risk concerns. Overall governance impact: mildly positive.

Codexis, Inc. (CDXS) ha ricevuto una comunicazione Form 4 da parte di Opaleye Management Inc., un azionista beneficiario del 10%, che dettaglia un acquisto sul mercato aperto completato il 27 giugno 2025.

  • Transazione: sono state acquistate 100.000 azioni ordinarie di Codexis (Codice P) a un prezzo medio di $2,39 per azione.
  • Detenzione post-transazione: Opaleye riporta ora un totale di 12.350.000 azioni detenute indirettamente tramite Opaleye, L.P. e ulteriori 250.000 azioni in un conto gestito separatamente, portando la proprietà beneficiaria totale segnalata a 12,6 milioni di azioni.
  • Forma di proprietà: Tutte le azioni sono riportate come indirette (Modulo I); il gestore degli investimenti nega la proprietà beneficiaria oltre il proprio interesse pecuniario.
  • Stato della parte segnalante: Opaleye è classificata come un azionista con oltre il 10% di partecipazione; non sono indicati ruoli nel consiglio o esecutivi.

La comunicazione indica un accumulo incrementale da parte di un grande azionista interno. Sebbene l’acquisto di 100.000 azioni sia modesto rispetto alla posizione di 12,35 milioni di azioni, l’acquisto può essere interpretato dagli investitori come un segnale di fiducia in Codexis ai livelli attuali di prezzo. Non sono state divulgate transazioni su derivati, vendite o opzioni in questa comunicazione.

Codexis, Inc. (CDXS) recibió una presentación Formulario 4 de Opaleye Management Inc., un propietario beneficiario del 10%, que detalla una compra en mercado abierto completada el 27 de junio de 2025.

  • հԲó: se adquirieron 100,000 acciones ordinarias de Codexis (Código P) a un precio promedio de $2.39 por acción.
  • Tenencia post-transacción: Opaleye reporta ahora 12,350,000 acciones mantenidas indirectamente a través de Opaleye, L.P. y otras 250,000 acciones en una cuenta gestionada por separado, sumando una propiedad beneficiaria total reportada de 12.6 millones de acciones.
  • Forma de propiedad: Todas las acciones se reportan como indirectas (Formulario I); el gestor de inversiones renuncia a la propiedad beneficiaria más allá de su interés pecuniario.
  • Estado de la parte reportante: Opaleye está clasificada como un propietario del 10%; no se indica ningún rol en la junta o ejecutivo.

La presentación señala una acumulación incremental por parte de un gran accionista interno. Aunque la compra de 100,000 acciones es modesta en relación con la posición de 12.35 millones de acciones, la compra fresca puede interpretarse por los inversores como un voto de confianza en Codexis a los niveles actuales de precio. No se divulgaron transacciones de derivados, ventas u opciones en esta presentación.

Codexis, Inc. (CDXS)� 10% 지� 보유자인 Opaleye Management Inc.로부� 2025� 6� 27�� 완료� 공개 시장 매수� 관� Form 4 신고� 받았습니�.

  • 거래 내용: Codexis 보통� 100,000주를 주당 평균 $2.39구매(코드 P)였습니�.
  • 거래 � 보유�: 貹� Opaleye, L.P.� 통해 간접적으� 12,350,000주와 별도� 관리되� 계좌� 250,000주를 보유하여 � 1,260� 주의 실질 소유권을 보고하고 있습니다.
  • 소유 형태: 모든 주식은 간접 소유(Form I)� 보고되었으며, 투자 매니저� 금전� 이익 이상� 실질 소유권을 부인합니다.
  • 보고� 지�: 貹� 10% 소유�� 분류되며, 이사회나 경영� 역할은 없습니다.

이번 신고� 대주주 내부자의 점진� 주식 매입� 나타냅니�. 100,000� 매수� 1,235� � 보유� 비해 적은 규모지�, 신규 매수� 투자자들에게 � 가� 수준에서 Codexis� 대� 신뢰� 표시� 해석� � 있습니다. 이번 신고에서� 파생상품 거래, 매도 또는 옵션 거래� 공개되지 않았습니�.

Codexis, Inc. (CDXS) a reçu un dépôt de Formulaire 4 de la part de Opaleye Management Inc., un détenteur bénéficiaire à 10%, détaillant un achat sur le marché ouvert réalisé le 27 juin 2025.

  • Transaction : 100 000 actions ordinaires de Codexis ont été achetées (Code P) à un prix moyen de 2,39 $ par action.
  • Position après transaction : Opaleye déclare désormais détenir indirectement 12 350 000 actions via Opaleye, L.P. et 250 000 actions supplémentaires dans un compte géré séparément, portant la propriété bénéficiaire totale déclarée à 12,6 millions ’aپDzԲ.
  • Forme de propriété : Toutes les actions sont déclarées comme indirectes (Formulaire I) ; le gestionnaire d’investissement décline toute propriété bénéficiaire au-delà de son intérêt pécuniaire.
  • Statut du déclarant : Opaleye est classé comme un détenteur de 10% ; aucun rôle au conseil d’administration ou exécutif n’est indiqué.

Le dépôt signale une accumulation progressive d’initiés par un grand actionnaire. Bien que l’achat de 100 000 actions soit modeste par rapport à la position de 12,35 millions d’actions, ce nouvel achat peut être interprété par les investisseurs comme un vote de confiance en Codexis aux niveaux de prix actuels. Aucune transaction sur dérivés, vente ou option n’a été divulguée dans ce dépôt.

Codexis, Inc. (CDXS) erhielt eine Form 4-Meldung von Opaleye Management Inc., einem 10%-Begünstigten, die einen am 27. Juni 2025 abgeschlossenen Kauf am offenen Markt beschreibt.

  • Transaktion: 100.000 Aktien der Codexis-Stammaktien wurden zu einem durchschnittlichen Preis von 2,39 $ pro Aktie gekauft (Code P).
  • Bestand nach der Transaktion: Opaleye meldet nun 12.350.000 Aktien, die indirekt über Opaleye, L.P. gehalten werden, sowie weitere 250.000 Aktien in einem separat verwalteten Konto, was eine insgesamt gemeldete wirtschaftliche Eigentümerschaft von 12,6 Millionen Aktien ergibt.
  • Form der Eigentümerschaft: Alle Aktien werden als indirekt (Formular I) gemeldet; der Investmentmanager lehnt eine wirtschaftliche Eigentümerschaft über sein pecuniäres Interesse hinaus ab.
  • Status der meldenden Partei: Opaleye wird als 10%-Գü eingestuft; keine Vorstands- oder Führungsfunktion wird angegeben.

Die Meldung signalisiert eine schrittweise Insider-Akkumulation durch einen Großaktionär. Obwohl der Kauf von 100.000 Aktien im Verhältnis zu der Position von 12,35 Millionen Aktien gering ist, kann der frische Kauf von Investoren als Vertrauensbeweis in Codexis zu den aktuellen Kursniveaus interpretiert werden. In dieser Meldung wurden keine Derivatgeschäfte, Verkäufe oder Optionen offengelegt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PICKETT C TAYLOR

(Last) (First) (Middle)
303 INTERNATIONAL CIRCLE
SUITE 200

(Street)
HUNT VALLEY MD 21030

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OMEGA HEALTHCARE INVESTORS INC [ OHI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF EXECUTIVE OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Profits Interest Units (1)(2) 06/30/2025 M 60,459 (3) (3) OP Units 60,459 $0 511,587 D
Profits Interest Units (1)(2) 06/30/2025 M 62,622 (4) (4) OP Units 62,622 $0 448,965 D
OP Units (2) 06/30/2025 M 60,459 (2) (2) Common Stock 60,459 $0 949,047 D
OP Units (2) 06/30/2025 M 62,622 (2) (2) Common Stock 62,622 $0 1,011,669 D
Explanation of Responses:
1. Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements.
2. Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. The OP Units have no expiration date.
3. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2025 based on the Absolute Total Shareholder Return for the 2022-2024 performance period, subject to continued employment and accelerated vesting under certain circumstances.
4. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2025 based on the Relative Total Shareholder Return for the 2022-2024 performance period, subject to continued employment and accelerated vesting under certain circumstances.
/s/ Meghan C. Lyons , Attorney-in-Fact 07/01/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many Codexis (CDXS) shares did Opaleye buy on 27 June 2025?

100,000 shares of common stock were purchased.

What was the purchase price for the insider transaction in CDXS?

The shares were acquired at $2.39 per share.

What is Opaleye’s total reported ownership in Codexis after the transaction?

Opaleye reports 12,350,000 shares via Opaleye, L.P. plus 250,000 in a managed account.

Did the Form 4 include any stock sales or derivative transactions?

No. The filing discloses only a purchase of common stock and reports no derivatives or sales.

Why is Opaleye considered a 10% owner of Codexis?

Its aggregated indirect holdings exceed 10% of Codexis� outstanding common stock, triggering Section 16 reporting.
Omega Healthcare

NYSE:OHI

OHI Rankings

OHI Latest News

OHI Latest SEC Filings

OHI Stock Data

11.30B
288.76M
0.21%
77.4%
5.42%
REIT - Healthcare Facilities
AG˹ٷ Estate Investment Trusts
United States
HUNT VALLEY